During the past decade, KKH Torgau conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "KKH Torgau" #1 sponsor was "Acotec Scientific Co., Ltd" with 1 trials, followed by "Daiichi Sankyo, Inc." with 1 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored, "German Breast Group" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "KKH Torgau" #1 collaborator was "ETOP IBCSG Partners Foundation" with 2 trials as a collaborator, "UNICANCER" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Austrian Breast & Colorectal Cancer Study Group" with 1 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "KKH Torgau" are "Advanced/Metastatic Breast Cancer" (1 trials), "Breast Cancer (Early Breast Cancer)" (1 trials), "Breast Cancer Stage II" (1 trials), "Breast Cancer Stage III" (1 trials) and "HER2-Positive Primary Breast Cancer" (1 trials). Many other conditions were trialed in "KKH Torgau" in a lesser frequency.

Most popular intervention types in "KKH Torgau" are "Drug" (5 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "AcoArt Orchid (0.035"), AcoArt Tulip (0.018") and AcoArt Litos (0.014") percutaneous transluminal angioplasty (PTA) paclitaxel drug coated balloon catheter manufactured by Acotec Scientific Co., Ltd." (1 trials), "Blood sampling" (1 trials), "Capecitabine" (1 trials), "Carboplatin" (1 trials) and "Cisplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "KKH Torgau" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "KKH Torgau". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in KKH Torgau, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in KKH Torgau, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".